Eruptive lentiginosis confined to areas of regressing psoriatic plaques after adalimumab treatment,

Eruptive lentiginosis confined to areas of regressing psoriatic plaques after adalimumab treatment,

Bibliographic Details
Main Author:	Fernando Garcia-Souto
Format:	Article
Language:	English
Published:	Sociedade Brasileira de Dermatologia 2021-03-01
Series:	Anais Brasileiros de Dermatologia
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962021000100113&tlng=en

Similar Items

RETRACTED: Eruptive lentiginosis in resolving psoriatic plaques
by: Robert Micieli, BSc, et al.
Published: (2018-05-01)

Isolated Palmoplantar Lentiginosis
by: Alghubaywi F, et al.
Published: (2023-06-01)

Adalimumab in treatment of psoriatic arthritis
by: V. V. Badokin
Published: (2008-08-01)

THE FIRST RUSSIAN EXPERIENCE OF ADALIMUMAB TREATMENT IN PSORIATIC ARTHRITIS
by: Elena Yurievna Loginova, et al.
Published: (2010-06-01)

Síndrome LEOPARD: variante del síndrome de Noonan con lentiginosis
by: Eloísa de Santiago García-Caro, et al.
Published: (2018-07-01)

A new eruption of bullous pemphigoid within psoriatic plaques following cyclosporine withdrawal
by: Katerina Svigos, BA, et al.
Published: (2021-02-01)

A case of vitiligo regression in a patient with psoriasis and psoriatic arthritis receiving adalimumab therapy
by: N. S. Rudneva, et al.
Published: (2021-12-01)

The effect of adalimumab on the vasculature in psoriatic skin lesions
by: S. C. A. Hanssen, et al.
Published: (2019-04-01)

Critical appraisal of adalimumab in the treatment of chronic plaque psoriasis
by: Nicolazzo D, et al.
Published: (2014-06-01)

Síndrome de Noonan con lentiginosis: manifestaciones dermatológicas sutiles y claves
by: B. Lozano-Masdemont, et al.
Published: (2021-10-01)

Erupção liquenóide: secundária ao uso de adalimumabe? Lichenoid eruption: secondary to adalimumab?
by: Maria Cristina Bezzan Goldschmidt, et al.
Published: (2008-04-01)

A Case Report of Adalimumab Successfully Treated a Severe Plaque Psoriasis Patient with Psoriatic End-Stage Renal Disease
by: Xu J, et al.
Published: (2023-10-01)

Cost per Responder Analysis of Secukinumab versus Adalimumab in the Treatment of Psoriatic Disease
by: Paolo Gisondi, et al.
Published: (2022-04-01)

Effectiveness of Adalimumab for the Treatment of Psoriatic Arthritis: An Italian Real-Life Retrospective Study
by: Salvatore D'Angelo, et al.
Published: (2019-12-01)

Acneiform eruptions and inflammatory striae as probable reactions to adalimumab
by: Shilpa Garg, et al.
Published: (2018-01-01)

The influence of adalimumab treatment on the systemic gene expression in patients with psoriatic arthritis – preliminary report
by: Agata Krawczyk, et al.
Published: (2021-03-01)

Etanercept, infliximab and adalimumab for the treatment of psoriatic arthritis: a systematic review and economic evaluation
by: M Rodgers, et al.
Published: (2011-02-01)

Visual Loss Induced by Adalimumab Used for Plaque Psoriasis
by: Norman Saffra, et al.
Published: (2017-03-01)

Multiple COVID reinfections in a vaccinated psoriatic patient receiving adalimumab
by: Omid Zargari, et al.
Published: (2022-11-01)

Psoriatic lesions over keloidal plaques after intralesional triamcinolone
by: Jyoti Yadav, et al.
Published: (2022-01-01)

Adalimumab treatment with and without methotrexate in patients with moderate to severe psoriatic arthritis: Results from adept
by: Kavanaugh, A, et al.
Published: (2005)

Erosions of Psoriatic Plaques Due to Methotrexate
by: Leandro Silva, et al.
Published: (2021-06-01)

QuantiFERON®-TB Gold test conversion in a psoriatic patient with pleural tuberculosis one year after adalimumab treatment
by: Tzu-Hung Huang
Published: (2018-03-01)

Successful Treatment of a Patient with Pyoderma Gangrenosum, Plaque Psoriasis and Palmoplantar Pustulosis with Adalimumab
by: Chu Y, et al.
Published: (2022-09-01)

Comparision of the efficacy and safety between Secukinumab and Adalimumab in the treatment of the moderate to severe plaque psoriasis
by: Dandan HU, et al.
Published: (2023-06-01)

Adalimumab-induced edema of the extremities in a psoriatic patient: a case report
by: Xiuqiu LIN, et al.
Published: (2023-08-01)

Description of the Clinical Case of Adalimumab and Secukinumab Therapy of a Patient with Psoriatic Arthritis
by: V. V. Didenko, et al.
Published: (2021-05-01)

Long-term use of adalimumab in the treatment of moderate to severe plaque psoriasis: a review of the literature
by: Angela Y Moore, et al.
Published: (2010-04-01)

Effects of adalimumab and secukinumab on comorbidities associated with metabolism in patients with plaque psoriasis
by: Si Zhang, et al.
Published: (2022-09-01)

Inhibition of radiographic progression in psoriatic arthritis by adalimumab independent of the control of clinical disease activity
by: Landewé, R, et al.
Published: (2019)

Effectiveness and safety of adalimumab in treating moderate to severe psoriasis patients with psoriatic arthritis in Taiwan
by: Pei-Han Kao, et al.
Published: (2015-09-01)

Partial Unilateral Lentiginosis Successfully Treated with the Combination of 511 nm and 578 nm Copper Bromide Laser in an Indonesian Woman
by: Hindritiani R, et al.
Published: (2023-08-01)

Multicentric squamous cell carcinoma arising on psoriatic plaque
by: Megha Gupta, et al.
Published: (2013-01-01)

Effects of secukinumab and adalimumab on serum uric acid level in patients with plaque psoriasis
by: Zheng Zhao, et al.
Published: (2022-06-01)

Comparative efficacy of tofacitinib and adalimumab in patients with psoriatic arthritis in real clinical practice. Data from the Russian nationwide register of patients with psoriatic arthritis
by: E. Yu. Loginova, et al.
Published: (2021-06-01)

Cutaneous Eruption after SARS-CoV-2 vaccine in psoriatic patient treated with methotrexate
by: Lembo Serena, et al.
Published: (2022-01-01)

Síndrome de Peutz-Jeghers: tratamento da lentiginose oral com laser Alexandrita Peutz-Jeghers Syndrome: treatment of oral lentiginosis with Alexandrite laser
by: Cristina Mansur, et al.
Published: (2003-08-01)

Impact of Adalimumab Treatment on Interleukin-17 and Interleukin-17 Receptor Expression in Skin and Synovium of Psoriatic Arthritis Patients with Mild Psoriasis
by: Janne W. Bolt, et al.
Published: (2022-01-01)

Adalimumab for the treatment of psoriasis
by: D Turner, et al.
Published: (2009-09-01)

Safety of treatment with adalimumab
by: G. V. Lukina, et al.
Published: (2008-04-01)